Researchers develop novel technology to quantify protein critical to blood clot formation through breath gas analysis

Immunothrombosis, or the formation of microscopic blood clots during inflammation, is a major cause of morbidity among patients with sepsis or severe COVID-19. A key enzyme in this process is thrombin. To date, no method exists for early detection of immunothrombosis in a living organism.

Leave A Comment

Your email address will not be published. Required fields are marked *